HYSSOP and POLIUM could help to prevent COVID-19 in a high-risk population: The results of a parallel randomized placebo-controlled field trial
HYSSOP and POLIUM could help to prevent COVID-19 in a high-risk population: The results of a parallel randomized placebo-controlled field trial
نویسندگان: سید محمد باقر فضل جو , جواد احمدیان هریس , عزیزه فرشباف خلیلی , احد بناگذار محمدی , پرویز شهابی , عباسعلی درستی , حامد همیشه کار , رئیس دانشگاه (آقای دکتر احمدرضا جودتی) , حجت پورفتحی نعمت آباد , یونس رنجبری , احسان سکاکی , نفیسه قصاب عبدالهی , هانیه صالحی پورمهر , سعید صفیری
کلمات کلیدی: COVID-19, HYSSOP, Medicinal herbs, POLIUM, Prevention
نشریه: 55216 , 2 , 21 , 2022
| نویسنده ثبت کننده مقاله |
جواد احمدیان هریس |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده پزشکی |
| کد مقاله |
78603 |
| عنوان فارسی مقاله |
HYSSOP and POLIUM could help to prevent COVID-19 in a high-risk population: The results of a parallel randomized placebo-controlled field trial |
| عنوان لاتین مقاله |
HYSSOP and POLIUM could help to prevent COVID-19 in a high-risk population: The results of a parallel randomized placebo-controlled field trial |
| ناشر |
18 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| This study was conducted to evaluate the effect of HYSSOP (composed of Hyssopus officinalis L., Echium amoenum
Fisch & C. A. Mey and Glycyrrhiza glabra L.) and POLIUM (contained Teucrium polium L., Cuscuta epithymum Murr and
Cichorium intybus L.) combined distilled herbal medicines compared to placebo in the prevention of COVID-19. This is a
double-blind parallel placebo-controlled field trial conducted on 751 asymptomatic individuals whose one of the
family members recently had a positive RT-PCR test for COVID-19. They were divided into three groups including
POLIUM, HYSSOP and placebo using random blocks with a 1:1:1 allocation ratio. Participants received daily 5 cc (under
12 years) or 10 cc (over 12 years) of allocated oral medications for 20 days. The primary outcome was the frequency of
positive RT-PCR test among participants who became symptomatic. The mean age of participants was 36.6. Nineteen
participants get infected by COVID-19 during the intervention; fifteen of them belonged to the placebo and four to the
POLIUM group. Fisher's exact test indicated significant differences between HYSSOP and placebo (p<0.001) as well as
POLIUM and placebo (p=0.009) groups in terms of COVID-19 confirmed by PCR tests. Cox regression model adjusted for
confounders illustrated that the hazard of getting infection by COVID-19 in POLIUM and HYSSOP groups decreased by
66% (OR (95% CI): 0.34 (0.12 to 0.94); p=0.038) and 93% (OR (95% CI): 0.07 (0.01to 0.56); p=0.012) respectively,
compared to placebo .Oral administration of HYSSOP and POLIUM with the other supportive health care could decrease
the risk of getting COVID-19 . |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 135 Hyssop-465607205-1-PB.pdf | 1401/02/10 | 701492 | دانلود |
| title page final.pdf | 1401/04/12 | 325637 | دانلود |